Global Defibrillator Market, By Product Type (Implantable Cardioverter Defibrillator and External Defibrillator), Patient Type (Adult, Pediatric), End Users(Hospitals, Clinics and Cardiac centres, Pre-hospital care settings, Public access markets, Home care settings, Alternate care facilities, Other end users) and opportunities and forecast 2020-2027
Defibrillator Market Overview
Cardiovascular disease (CVD) is a leading cause of death and disability across the world.Attributable to this, the demand for defibrillators has raised, as these devices facilitate save the lives of patients at a high risk of pathology.
The prevalence of lifestyle diseases like hypertension, obesity, dyslipidemia, and diabetes, that are major risk factors for CVD, is additionally on the increase. there's a strong linear relationship between high pressure levels and therefore the risk of developing CVDs. In the US, around 70th of people UN agency have suffered from their 1st vessel stroke, their 1st attack, and UN agency have congestive heart failure, are reportable to own a pressure of over 140/90 pressure unit.
The rising geriatric population across the world is another key issue conducive to the increasing prevalence of CVD, as aging is related to progressive deterioration within the structure and performance of the heart and acts as a catalyst within the development of chronic diseases. Thus, with the expansion within the geriatric population across the world, the incidence of heart diseases is predicted to extend.
AEDs put in publically places are typically liable to failure because of issues touching on the battery, software, and hardware. Failure to perform medical aid may end up in delayed treatment or maybe death. Over the years, variety of defibrillators are recalled because of technical errors within the functioning of the device with relation to shock delivery, electrical problems, and hardware configuration. These defects could result in undesirable product performance and even the death of the patient in some cases. In 2018, the FDA, in conjunction with Philips, issued a recall notice for numerous models of the HeartStart MRx electronic device. The recall was caused by a defect within the gas discharge tube (GDT), that may lead to the malfunction of the electronic device. In 2021, Medtronic recalled the Evera, Viva, Brava, Claria, Amplia, Compia, and Visa ICDs and CRT-Ds because of the short battery life related to these devices.
Cybersecurity is another major concern within the defibrillators market. The new generation of implantable defibrillators is technologically advanced, granting remote knowledge transfer. The agency has raised issues relating to the hacking of those devices. Medtronic was the most recent company to face Associate in Nursing agency cybersecurity issue in 2019, as Medtronic’s wireless measure technology didn't have encoding or authentication safety.
The covid-19 Impact on Defibrillator Market:
|Market size available for years
|Base year considered
||Value (USD Million)
||Grade, Application and Region
||North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA)
||Medtronic ,Stryker Corporation ,Koninklijke Philips N.V. ,Asahi Kasei Corporation ,Boston Scientific Corporation , Abbott, Nihon Kohden , MicroPort ,BIOTRONIK ,CU Medical Systems .
Like several different industries, COVID-19 badly knocked the electronic and semiconductor trade. This new event has compact nearly 230 countries in exactly a couple of weeks, leading to the forced conclusion of producing and transportation activities at intervals and across the countries. This has directly affected the expansion of the sector. It's calculable that COVID-19 to depart over USD thirty billion impacts on the physics and semiconductor trade. The arena is majorly affected thanks to transport restrictions on major physics and semiconductor staple suppliers. However, the rising want for semiconductors in many industries can supply fast market recovery over the longer-term amount. Defibrillator Market Segment Overview
Based on product type, the defibrillator market is defibrillator into implantable cardiovascular defibrillators and external defibrillators. The implantable cardiovascular electronic device (ICDs) phase is anticipated to dominate this market throughout the forecast period. the large share of this market segment the large attributed to the increasing prevalence of cardiovascular diseases and therefore the development of technologically advanced defibrillators.
Based on patient types, the defibrillator market is segmented into adult and pediatric. The adult patient phase phase accounted for the largest market share in 2020. The adult patients segment dominated the worldwide defibrillators market with a share of largest in 2020.
Based on end users, the defibrillators market is segmented into hospitals, clinics, and viscus centers; prehospital care settings; public-access markets; alternate care facilities; home care settings; and different end users. The hospitals, clinics, and viscus centers phase dominated the global defibrillators market, with a share of largest , in 2020.
Market Analysis, Insights and Forecast – By Product Type
· Implantable Cardiovascular Defibrillator
· External Defibrillator
Market Analysis, Insights and Forecast – By Patient Type
Market Analysis, Insights and Forecast – By Application
· Clinics and Cardiac centres
· Pre-hospital care settings
· Public access markets
· Home care settings
· Alternate care facilities
· Other end usersDefibrillator Market Regional Overview
Region-wise, in terms of regions, On the basis of region, the defibrillator market is segmented into North America, Europe, Asia Pacific, latin america, and also the middle east & Africa. The Asia Pacific region the highest to register the highest growth during the forecast amount. The Asia Pacific is segmental into China, India, Japan, south korea, Australia, and also the remainder of Asia Pacific, as well as Asian nation, Taiwan, Singapore, and New zealand.
Defibrillator Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA) Defibrillator Market Competitor overview
Some key developments and strategies adopted by manufacturers in the Defibrillator are highlighted below.
· In 2020, Abbott received FDA approval for its next generation ICDs and CRT-Ds underneath the brand Gallant. Defibrillator Market, Key Players
· Stryker Corporation
· Koninklijke Philips N.V.
· Asahi Kasei Corporation
· Boston Scientific Corporation
· Nihon Kohden
· CU Medical Systems
Frequently Asked Questions (FAQ) :
Q1. What is the total CAGR expected to be recorded for the Defibrillator market during the forecast period?
A. Defibrillator market is expected to record a CAGR of ~ 9.8% during the forecast period.
Q2. Which segment is projected to hold the largest share in the Defibrillator Market?
A. Adult segment is projected to hold the largest share in the Defibrillator Market
Q3. What are the driving factors for the Defibrillator market?
A. Cardiovascular disease (CVD) is a leading cause of death and disability across the world is key factors that boost the growth of the Defibrillator market progressively.
Q4. Which Segments are covered in the Defibrillator market report?
A. Product Type, Patient Type and Application, and Region, these segments are covered in the Defibrillator market report.
Q5. Which are the prominent players offering Defibrillator ?
A. Medtronic ,Stryker Corporation ,Koninklijke Philips N.V. ,Asahi Kasei Corporation ,Boston Scientific Corporation , Abbott, Nihon Kohden , MicroPort ,BIOTRONIK ,CU Medical Systems .